Illumina Inc

Market Summary

USD116.35-0.78

Delayedas of 08 Dec 2023, 10:00 am

-0.67%

ILMN Alerts

Big jump in Earnings (Y/Y)
Losses in recent quarter

ILMN Stock Price

View Fullscreen

ILMN RSI Chart

ILMN Alerts

Big jump in Earnings (Y/Y)
Losses in recent quarter

ILMN Valuation

Market Cap

18.5B

Price/Earnings (Trailing)

-16.46

Price/Sales (Trailing)

4.14

EV/EBITDA

-21.49

Price/Free Cashflow

109.51

ILMN Price/Sales (Trailing)

ILMN Profitability

Operating Margin

62.23%

EBT Margin

-89.82%

Return on Equity

-63.86%

Return on Assets

-35.55%

Free Cashflow Yield

0.91%

ILMN Fundamentals

ILMN Revenue

Revenue (TTM)

4.5B

Revenue Y/Y

0.36%

Revenue Q/Q

-4.85%

ILMN Earnings

Earnings (TTM)

-1.1B

Earnings Y/Y

80.24%

Earnings Q/Q

-222.22%

Price Action

52 Week Range

115.22238.55

(Low)(High)

Last 7 days

14.9%

Last 30 days

2.3%

Last 90 days

-26.0%

Trailing 12 Months

-43.8%

How does ILMN drawdown profile look like?

ILMN Financial Health

Current Ratio

1.4

ILMN Investor Care

Shares Dilution (1Y)

0.64%

Diluted EPS (TTM)

-7.11

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	4.4B	4.5B	4.5B	0
2022	4.7B	4.7B	4.7B	4.6B
2021	3.5B	4.0B	4.3B	4.5B
2020	3.6B	3.4B	3.2B	3.2B
2019	3.4B	3.4B	3.5B	3.5B
2018	2.9B	3.1B	3.2B	3.3B
2017	2.4B	2.5B	2.6B	2.8B
2016	2.3B	2.3B	2.4B	2.4B
2015	2.0B	2.1B	2.1B	2.2B
2014	1.5B	1.6B	1.7B	1.9B
2013	1.2B	1.3B	1.3B	1.4B
2012	1.0B	1.0B	1.1B	1.1B
2011	993.1M	1.1B	1.1B	1.1B
2010	692.7M	743.1M	822.0M	902.7M
2009	596.5M	619.8M	643.0M	666.3M
2008	0	0	0	573.2M

Get all data in R, Python etc through our Historical Stock Data APIs

Latest Insider Trading transactions for ILMN

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Nov 07, 2023	hoyt aimee l	sold	-35,544	112	-315	svp, chief people officer
Nov 05, 2023	ericksen scott d	sold (taxes)	-34,529	112	-306	vp, chief accounting officer
Nov 05, 2023	rollins carissa	sold (taxes)	-45,587	112	-404	svp, chief information officer
Nov 05, 2023	goswami joydeep	sold (taxes)	-212,929	112	-1,887	svp, chief financial officer
Nov 05, 2023	barnard steven	sold (taxes)	-62,400	112	-553	svp, chief technology officer
Nov 05, 2023	reeves kathryne gambrell	sold (taxes)	-81,921	112	-726	svp, chief marketing officer
Nov 05, 2023	tousi susan h	sold (taxes)	-200,968	112	-1,781	svp, chief commercial officer
Nov 05, 2023	hoyt aimee l	sold (taxes)	-136,424	112	-1,209	svp, chief people officer
Nov 05, 2023	pegels kevin carl	sold (taxes)	-86,322	112	-765	chief of global operations
Nov 05, 2023	dadswell charles	sold (taxes)	-171,855	112	-1,523	svp, general counsel

Which funds bought or sold ILMN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Dec 06, 2023	CITIGROUP INC	added	42.65	2,180,250	51,220,400	0.04%
Dec 06, 2023	VisionPoint Advisory Group, LLC	added	344	23,681	34,181	0.01%
Dec 04, 2023	Phoenix Holdings Ltd.	added	119	167,792	458,622	-%
Dec 04, 2023	TUCKER ASSET MANAGEMENT LLC	unchanged	-	-552	1,510	-%
Dec 01, 2023	B. Riley Wealth Advisors, Inc.	reduced	-70.04	-1,263,830	356,516	0.01%
Nov 30, 2023	Neo Ivy Capital Management	sold off	-100	-1,831,000	-	-%
Nov 29, 2023	Decheng Capital Management III (Cayman), LLC	unchanged	-	-4,059,930	11,100,300	3.55%
Nov 28, 2023	IMA Wealth, Inc.	reduced	-0.96	-177,554	468,537	0.12%
Nov 27, 2023	TRUST CO OF VERMONT	sold off	-100	-9,937	-	-%
Nov 27, 2023	BANQUE PICTET & CIE SA	unchanged	-	-513,448	1,403,820	0.02%

Latest Funds Activity

Are funds buying ILMN calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ILMN

No. of Funds

Schedule 13G FIlings of Illumina Inc

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Dec 05, 2023	baillie gifford & co	3.36%	5,332,416	SC 13G/A
Nov 20, 2023	baillie gifford & co	5.44%	8,608,269	SC 13G/A
Oct 10, 2023	vanguard group inc	11.35%	17,966,765	SC 13G/A
Feb 14, 2023	edgewood management llc	4.1%	6,478,370	SC 13G/A
Feb 09, 2023	vanguard group inc	8.28%	13,022,627	SC 13G/A
Jan 31, 2023	blackrock inc.	7.7%	12,051,653	SC 13G/A
Jan 20, 2023	baillie gifford & co	10.64%	16,743,103	SC 13G/A
Feb 14, 2022	edgewood management llc	5.6%	8,742,202	SC 13G
Feb 03, 2022	blackrock inc.	7.5%	11,784,218	SC 13G/A
Jan 20, 2022	baillie gifford & co	13.10%	20,480,537	SC 13G/A

Recent SEC filings of Illumina Inc

View All Filings

Date Filed	Form Type	Document
Dec 05, 2023	SC 13G/A	Major Ownership Report
Nov 20, 2023	SC 13G/A	Major Ownership Report
Nov 13, 2023	10-Q	Quarterly Report
Nov 13, 2023	8-K/A	Current Report
Nov 09, 2023	4	Insider Trading
Nov 09, 2023	8-K	Current Report
Nov 09, 2023	8-K/A	Current Report
Nov 07, 2023	4	Insider Trading
Nov 07, 2023	144	Notice of Insider Sale Intent
Nov 07, 2023	4	Insider Trading

ILMN Fair Value

Peers (Alternatives to Illumina Inc)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
DHR	161.6B	29.6B	10.34%	-18.45%	27.32	5.47	-5.39%	-12.54%
IDXX	43.5B	3.6B	23.81%	24.51%	52.81	12.11	7.43%	22.86%
A	37.7B	7.0B	16.41%	-16.29%	33.28	5.39	5.03%	-14.68%
DGX	15.1B	9.3B	1.76%	-9.25%	19.85	1.63	-9.69%	-38.22%
EXAS	11.7B	2.4B	-0.52%	41.53%	-41.63	4.88	19.99%	60.62%
MID-CAP
CRL	10.4B	4.2B	10.89%	-4.83%	21.89	2.47	11.49%	8.84%
MEDP	8.6B	1.8B	2.53%	36.18%	31.61	4.85	29.62%	20.49%
NTRA	6.9B	988.7M	32.77%	50.65%	-13.81	6.97	27.41%	8.51%
NEOG	4.0B	919.1M	16.80%	19.47%	-149.36	4.32	73.02%	-172.93%
GH	3.1B	535.8M	0.15%	-45.50%	-7.16	5.78	24.38%	26.34%
SMALL-CAP
CDNA	526.9M	297.1M	46.76%	-25.50%	-5.82	1.77	-6.74%	-21.60%
ACRS	70.8M	21.4M	-81.37%	-93.35%	-0.62	3.3	-8.80%	-39.66%
AWH	31.8M	9.2M	-16.29%	-21.48%	-1.8	3.46	16.43%	48.38%
APDN	13.9M	16.1M	12.50%	-25.52%	-1.98	0.86	-8.51%	41.77%
BIOC	120.4K	-	-82.76%	-93.43%	0	0.76	-57.78%	-93.13%

Illumina Inc News

Latest updates

Stockhouse Publishing • 07 Dec 2023 • 04:03 pm • 23 hours ago

2023-12-07 | NDAQ:ILMN | Press Release | Illumina Inc

MarketBeat • 07 Dec 2023 • 02:27 pm • 24 hours ago

59268 Shares in Illumina, Inc. (NASDAQ:ILMN) Acquired by ...

InvestorsObserver • 06 Dec 2023 • 08:03 pm • 43 hours ago

Illumina, Inc. (ILMN) Stock: What Does the Chart Say Wednesday?

Nasdaq • 06 Dec 2023 • 07:00 pm • 44 hours ago

ILMN Factor-Based Stock Analysis

London South East • 06 Dec 2023 • 02:29 pm • 2 days ago

US open: Dow tries to shake off two-day losing streak | Financial News

MarketBeat • 06 Dec 2023 • 01:35 pm • 2 days ago

Leerink Partnrs Comments on Illumina, Inc.'s Q3 2025 Earnings ...

DirectorsTalk Interviews • 05 Dec 2023 • 02:12 pm • 3 days ago

Illumina, Inc. - Consensus 'hold' rating and 19.8% Upside Potential

London South East • 04 Dec 2023 • 11:56 pm • 3 days ago

US close: Stocks lower as investors look to jobs report | Financial ...

Simply Wall St • 03 Dec 2023 • 02:53 pm • 5 days ago

Is Illumina, Inc. (NASDAQ:ILMN) Potentially Undervalued?

InvestorsObserver • 01 Dec 2023 • 07:27 pm • 6 days ago

Is Illumina, Inc. (ILMN) Stock Worth a Buy Friday?

GlobeNewswire • 28 Nov 2023 • 12:45 am • 10 days ago

Illumina, Inc. (ILMN) Class Action Alert: Robbins LLP Reminds ...

GlobeNewswire • 26 Nov 2023 • 02:00 am • 12 days ago

ILLUMINA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors ...

InvestorsObserver • 20 Nov 2023 • 07:51 pm • 17 days ago

Is Illumina, Inc. (ILMN) Stock a Smart Value Monday?

Business Wire • 20 Nov 2023 • 08:00 am • 18 days ago

ILMN Stock News: Shareholders with Significant Losses Should ...

MarketWatch • 17 Nov 2023 • 10:12 pm • 20 days ago

Illumina Inc. stock underperforms Friday when compared to competitors

Financials for Illumina Inc

Income Statement (Last 12 Months)
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Revenue	-4.8%	1,119	1,176	1,087	1,084	1,115	1,162	1,223	1,199	1,108	1,126	1,093	953	794	633	859	953	907	838	846	867	853
Cost Of Revenue	-2.0%	435	444	432	411	398	395	408	382	338	324	329	323	268	205	240	290	259	265	262	278	256
Gross Profit	-6.6%	684	732	655	673	717	767	815	818	770	802	764	630	526	428	619	662	648	573	584	590	597
Operating Expenses	75.4%	1,438	820	719	800	4,374	1,346	631	776	1,315	615	571	497	364	332	430	394	340	368	380	393	356
S&GA Expenses	-32.7%	303	450	378	433	146	410	308	426	879	413	374	298	192	177	274	233	189	202	211	217	197
R&D Expenses	-12.0%	315	358	341	346	325	327	323	350	436	202	197	199	172	155	156	161	151	166	169	176	159
EBITDA Margin	100.0%	-	-0.83*	-0.97*	-0.89*	-0.82*	0.05*	0.25*	0.26*	0.32*	0.29*	0.31*	0.34*	0.33*	0.33*	0.37*	0.38*	-	-	-	-	-
Interest Expenses	0%	19.00	19.00	20.00	9.00	6.00	6.00	6.00	13.00	14.00	16.00	19.00	16.00	11.00	11.00	11.00	11.00	11.00	15.00	15.00	20.00	15.00
Income Taxes	-119.3%	-28.00	145	-81.00	-28.50	144	-102	54.00	-25.50	103	22.00	22.00	42.00	36.00	118	5.00	30.00	36.00	53.00	9.00	12.00	44.00
Earnings Before Taxes	-778.7%	-782	-89.00	-78.00	-167	-3,672	-637	140	87.00	420	207	169	299	215	165	178	269	270	346	233	209	232
EBT Margin	100.0%	-	-0.90*	-1.02*	-0.95*	-0.87*	0.00*	0.18*	0.20*	0.26*	0.22*	0.24*	0.26*	0.26*	0.26*	0.30*	0.32*	-	-	-	-	-
Net Income	-222.2%	-754	-234	3.00	-139	-3,816	-535	86.00	113	317	185	147	257	179	47.00	173	239	234	296	233	210	199
Net Income Margin	100.0%	-	-0.94*	-1.01*	-0.96*	-0.88*	0.00*	0.15*	0.17*	0.21*	0.19*	0.18*	0.20*	0.20*	0.21*	0.26*	0.28*	-	-	-	-	-
Free Cashflow	-100.0%	-	58.00	-42.00	59.00	-118	54.00	111	212	-324	209	240	344	105	201	241	386	-	-	-	-	-

Balance Sheet
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Assets	-14.0%	10,122	11,774	11,811	12,252	11,256	15,448	15,274	15,217	15,063	8,675	8,755	7,585	7,404	7,248	7,261	7,316	7,089	6,973	7,390	6,959	6,759
Current Assets	-22.2%	2,506	3,223	3,172	3,561	2,487	2,891	2,755	2,713	2,451	5,310	5,642	4,483	4,329	4,194	4,324	4,451	4,222	4,156	4,545	4,490	4,262
Cash Equivalents	-40.3%	927	1,553	1,494	2,011	1,000	1,289	1,351	1,232	1,080	4,196	4,433	1,810	1,761	1,770	1,991	2,042	1,815	1,943	2,270	1,144	1,346
Inventory	-0.3%	615	617	586	568	559	518	465	431	401	380	364	372	415	435	384	359	417	420	412	386	374
Net PPE	-2.7%	1,040	1,069	1,082	1,091	1,068	1,055	1,034	1,024	1,009	915	915	922	910	890	890	889	875	854	852	834	1,060
Goodwill	-22.0%	2,527	3,239	3,239	3,239	3,238	7,158	7,113	7,113	7,098	966	897	897	897	894	824	897	824	824	831	831	831
Current Liabilities	-35.6%	1,482	2,303	2,230	2,773	2,669	2,881	1,490	1,093	914	874	1,268	1,244	1,115	1,115	1,054	665	619	612	1,241	1,804	1,735
LT Debt, Current	-	-	-	-	-	-	-	499	-	-	-	-	511	507	503	499	-	-	-	631	838	1,107
LT Debt, Non Current	-	-	-	-	-	-	-	-	-	-	-	-	673	666	659	652	1,141	1,131	1,120	1,112	890	860
Shareholder's Equity	-10.0%	5,898	6,555	6,693	6,599	6,731	10,444	10,895	10,740	10,593	5,180	4,922	4,694	4,700	4,563	4,635	4,613	4,439	4,332	4,070	3,845	3,594
Retained Earnings	-82.8%	157	911	1,145	1,142	1,281	5,097	5,632	5,485	5,372	5,055	4,870	4,723	4,466	4,287	4,240	4,067	3,828	3,594	3,298	3,083	2,872
Additional Paid-In Capital	1.0%	9,487	9,397	9,311	9,207	9,129	9,033	8,957	8,938	8,849	3,993	3,914	3,815	3,737	3,649	3,631	3,560	3,510	3,436	3,385	3,290	3,093
Accumulated Depreciation	-	-	-	-	962	-	-	-	796	-	-	-	678	-	-	-	-	-	-	-	-	-
Shares Outstanding	-100.0%	-	158	158	158	157	157	157	157	152	146	146	146	146	147	147	147	147	147	147	147	147
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	85.00	87.00	91.00

Cashflow (Last 12 Months)
(In Millions)

Cashflow (Quarterly)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Cashflow From Operations	32.4%	139,000,000	105,000,000	10,000,000	147,000,000	-52,000,000	125,000,000	172,000,000	282,000,000	-272,000,000	253,000,000	282,000,000	406,000,000	153,000,000	240,000,000	281,000,000	443,000,000	267,000,000	143,000,000	198,000,000	300,000,000	292,000,000
Share Based Compensation	-17.9%	87,000,000	106,000,000	93,000,000	100,000,000	83,000,000	91,000,000	92,000,000	98,000,000	509,000,000	80,000,000	67,000,000	78,000,000	61,000,000	16,000,000	39,000,000	49,000,000	46,000,000	48,000,000	51,000,000	47,000,000	48,000,000
Cashflow From Investing	-43.2%	-53,000,000	-37,000,000	-56,000,000	-102,000,000	-250,000,000	-165,000,000	-74,000,000	-	-2,448,000,000	3,000,000	1,376,000,000	-34,000,000	-65,000,000	-320,000,000	-135,000,000	-104,000,000	-218,000,000	79,000,000	988,000,000	-348,000,000	-940,000,000
Cashflow From Financing	-23466.7%	-707,000,000	-3,000,000	-473,000,000	956,000,000	28,000,000	-5,000,000	21,000,000	-129,000,000	-394,000,000	-496,000,000	968,000,000	-331,000,000	-101,000,000	-143,000,000	-191,000,000	-115,000,000	-173,000,000	-549,000,000	-60,000,000	-154,000,000	651,000,000
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	281,000,000	125,000,000	142,000,000	188,000,000	63,000,000	198,000,000	-	63,000,000	98,000,000	-

ILMN Income Statement

2023-10-01

Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Revenue:
Total revenue	$ 1,119	$ 1,115	$ 3,382	$ 3,501
Cost of revenue:
Amortization of acquired intangible assets	47	46	143	125
Total cost of revenue	435	398	1,312	1,201
Gross profit	684	717	2,070	2,300
Operating expense:
Research and development	315	325	1,013	975
Selling, general and administrative	303	146	1,127	865
Goodwill and intangible impairment	821	3,914	821	3,914
Legal contingency and settlement	(1)	(11)	14	598
Total operating expense	1,438	4,374	2,975	6,352
Loss from operations	(754)	(3,657)	(905)	(4,052)
Other income (expense):
Interest income	13	3	47	4
Interest expense	(19)	(6)	(59)	(17)
Other expense, net	(22)	(12)	(33)	(103)
Total other expense, net	(28)	(15)	(45)	(116)
Loss before income taxes	(782)	(3,672)	(950)	(4,168)
(Benefit) provision for income taxes	(28)	144	36	97
Net loss	$ (754)	$ (3,816)	$ (986)	$ (4,265)
Loss per share:
Basic (in dollars per share)	$ (4.77)	$ (24.26)	$ (6.23)	$ (27.13)
Diluted (in dollars per share)	$ (4.77)	$ (24.26)	$ (6.23)	$ (27.13)
Shares used in computing loss per share:
Basic (in shares)	158	157	158	157
Diluted (in shares)	158	157	158	157
Product revenue
Revenue:
Total revenue	$ 941	$ 963	$ 2,864	$ 3,039
Cost of revenue:
Cost of revenue	293	280	884	866
Service and other revenue
Revenue:
Total revenue	178	152	518	462
Cost of revenue:
Cost of revenue	$ 95	$ 72	$ 285	$ 210

ILMN Balance Sheet

2023-10-01

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Oct. 01, 2023	Jan. 01, 2023
Current assets:
Cash and cash equivalents	$ 927	$ 2,011
Short-term investments	6	26
Accounts receivable, net	690	671
Inventory, net	615	568
Prepaid expenses and other current assets	268	285
Total current assets	2,506	3,561
Property and equipment, net	1,040	1,091
Operating lease right-of-use assets	581	653
Goodwill	2,527	3,239
Intangible assets, net	3,029	3,285
Other assets	439	423
Total assets	10,122	12,252
Current liabilities:
Accounts payable	240	293
Accrued liabilities	1,242	1,232
Term notes, current portion	0	500
Convertible senior notes, current portion	0	748
Total current liabilities	1,482	2,773
Operating lease liabilities	698	744
Term notes	1,489	1,487
Other long-term liabilities	555	649
Stockholders’ equity:
Common stock	2	2
Additional paid-in capital	9,487	9,207
Accumulated other comprehensive income	21	3
Retained earnings	157	1,142
Treasury stock, at cost	(3,769)	(3,755)
Total stockholders’ equity	5,898	6,599
Total liabilities and stockholders’ equity	$ 10,122	$ 12,252

About Illumina Inc

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

CEO	Mr. Charles E. Dadswell Esq.
WEBSITE	www.illumina.com
EMPLOYEES	11500

Illumina Inc Frequently Asked Questions

What is the ticker symbol for Illumina Inc? What does ILMN stand for in stocks?

ILMN is the stock ticker symbol of Illumina Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Illumina Inc (ILMN)?

As of Thu Dec 07 2023, market cap of Illumina Inc is 18.51 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ILMN stock?

You can check ILMN's fair value in chart. The fair value of Illumina Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Illumina Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ILMN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Illumina Inc a good stock to buy?

The fair value guage provides a quick view whether ILMN is over valued or under valued. Whether Illumina Inc is cheap or expensive depends on the assumptions which impact Illumina Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ILMN.

What is Illumina Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Dec 07 2023, ILMN's PE ratio (Price to Earnings) is -16.46 and Price to Sales (PS) ratio is 4.14. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ILMN PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Illumina Inc's stock?

In the past 10 years, Illumina Inc has provided 0.015 (multiply by 100 for percentage) rate of return.

Market Summary

ILMN Alerts

ILMN Stock Price

ILMN RSI Chart

ILMN Alerts

ILMN Valuation

ILMN Price/Sales (Trailing)

ILMN Profitability

ILMN Fundamentals

ILMN Revenue

ILMN Earnings

Price Action

52 Week Range

How does ILMN drawdown profile look like?

ILMN Financial Health

ILMN Investor Care

Historical Charts for Stock Metrics

Latest Insider Trading transactions for ILMN

Which funds bought or sold ILMN recently?

Latest Funds Activity

Schedule 13G FIlings of Illumina Inc

Recent SEC filings of Illumina Inc

ILMN Fair Value

Peers (Alternatives to Illumina Inc)

Illumina Inc News

Financials for Illumina Inc

Income Statement (Last 12 Months).css-zgnqz2{margin:0;font-family:"Roboto","Helvetica","Arial",sans-serif;font-weight:400;font-size:0.75rem;line-height:1.66;letter-spacing:0.03333em;color:#595959;}(In Millions)

Balance Sheet(In Millions)

Cashflow (Last 12 Months)(In Millions)

ILMN Income Statement

ILMN Balance Sheet

About Illumina Inc

Illumina Inc Frequently Asked Questions

What is the ticker symbol for Illumina Inc? What does ILMN stand for in stocks?

What is the market capital of Illumina Inc (ILMN)?

What is the fair value of ILMN stock?

Is Illumina Inc a good stock to buy?

What is Illumina Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

What is 5 year return on Illumina Inc's stock?

Income Statement (Last 12 Months)
(In Millions)

Balance Sheet
(In Millions)

Cashflow (Last 12 Months)
(In Millions)